Course Report: 2nd Speech and Swallowing in Parkinson's Disease School

2nd Speech and Swallowing in Parkinson's Disease School

London, United Kingdom – July 6-7, 2018

Course Narrative

The 2nd Speech and Swallowing in Parkinsons' Disease School participants gather for a photo in London, United Kingdom, July 2018.The main objective of the 2nd Speech and Swallowing in Parkinson’s Disease School was to provide an opportunity for speech therapists and other health professionals to stay informed on the clinical aspects of Parkinsonism, as well as to provide the most recent knowledge about clinical management of dysarthria in Parkinson’s disease.  During the school, esteemed course faculty provided recommendations while educating students, clinicians and researchers in order to improve their understanding of speech impairment in Parkinson’s disease as a multidimensional, multidisciplinary and multiparametric symptom.

The school took place over two days at the Queen Square Lecture Theater with lectures given by faculty from around the world.  Day one’s morning lecture topics covered atypical parkinsonism and the variability of speech symptoms, followed by a lecture on communication changes through the disease process from the patient’s perspective and lectures on how to study these changes and dissect speech impairment.  The afternoon provided an opportunity for small group speech assessment and treatment workshops.  The end of the day covered the pharmacological and surgical treatments for Parkinson’s disease and their effects on speech.

Lectures continued on the final day of the course with content on the neurophysiology of swallowing in PD, assessing swallowing function in PD, treating swallowing discords in PD, and saliva production and management options.  In the afternoon, participants experienced a video fluroscopy workshop and a virtual expiratory muscle strength training workshop.  The remaining lectures discussed the various technologies used for enhancing the clinical practice.  To wrap up the final day, a novel topic was presented upon regarding the non-motor symptoms in speech and swallowing rehabilitation.

Overall, the participants and faculty were exceptionally pleased with the course.  Many expressed interest in attending another Speech School in the future.

Target vs. Actual Audience

This course was targeted towards speech therapists and speech pathologists, neurologists and ENTs, health professionals specialized in Parkinson’s disease management, speech scientists, and neuroscientists.

Course Learning Objectives

At the conclusion of this activity, participants should be able to accomplish the following:

  • Discuss the neurological bases of normal speech production and speech impairment in PD and atypical parkinsonism
  • Assess speech impairment and swallowing impairment in PD and its implications on social participation
  • Select and design a rehabilitation program targeting speech and/or swallowing impairments in PD patients
  • Consider technological advances for assessing and treating and monitoring speech and swallowing problems
  • Appreciate the challenge of treating speech impairment as part of a multidisciplinary team
  • Consider patient-reported outcome measures as part of the evaluation and follow-up program of management
  • Identify how and when speech therapy can be fully effective according to disease progression and in association with medical and/or surgical treatments

 

Accreditation Information

LSVT Global is approved by the Continuing Education Board of the American Speech-Language-Hearing Association (ASHA) to provide continuing education activities in speech-language pathology and audiology. See course information for number of ASHA CEUs, instructional level and content area. ASHA CE Provider approval does not imply endorsement of course content, specific products or clinical procedures.

This course is offered for 1.25 CEUs (Advanced level; Professional area).

Participant Feedback

At the conclusion of the course, participants were asked what they would change about their professional or clinical practice. A few participant responses acknowledged that they will consider implementing technological advances for assessing and monitoring speech disorders. They will be better able to design rehabilitation programs targeting people with Parkinsonism and DBS, according to disease progression, also considering social participation outcome measures as part of the evaluation. Another participant said they would implement newly learned diagnostic methods of assessment and treatment of speech and swallowing disorders into their daily practice. Many believe that the quality of diagnostics will be improved within their practice, including the timeliness of adequate therapy and the improvement of quality of life for patients.

Participants were asked how they would improve this activity. Many had nothing to add, noting that their experience at the course was all around a positive one. Multiple comments were added expressing an interest in more workshops and group discussion on how Movement Disorders practice differs in different countries. Another participant recommended providing additional information about rehabilitation programs targeting swallowing impairments, electrical stimulation, for example. Multiple participants also expressed an interest in seeing more videos about clinical cases and videos with patient evaluation.

All around, the participant feedback was very positive and complimentary.

Attendance                                                                                                                                  

This course educated 43 participants from 19 different countries.

 

Top

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice